Penta-1,2,3,4,6-O-galloyl-beta-D-glucose induces senescence-like terminal S-phase arrest in human hepatoma and breast cancer cells

Molecular Carcinogenesis

Volumn 50, Issue 8, 2011, Pages 592-600

  Yin, Shutao ^a   Dong, Yinhui ^a   Li, Jinhua ^a   Lü, Junxuan ^b   Hu, Hongbo ^a  

^a CHINA AGRICULTURAL UNIVERSITY   (China)

^b UNIVERSITY OF MINNESOTA   (United States)

Author keywords

Liver and breast cancer cells; P53 p21; Permanent growth arrest; PGG; ROS

Indexed keywords

ANTINEOPLASTIC AGENT; BETA GALACTOSIDASE; CYCLIN DEPENDENT KINASE INHIBITOR 1; GLUCOSE DERIVATIVE; HISTONE H2AX; PENTA 1,2,3,4,6 O GALLOYL BETA DEXTRO GLUCOSE; PROTEIN P53; REACTIVE OXYGEN METABOLITE; SERINE; TANNIN; UNCLASSIFIED DRUG;

ARTICLE; BREAST CANCER; CANCER CELL CULTURE; CELL AGING; CELL CYCLE ARREST; CELL CYCLE S PHASE; CELL PROLIFERATION; CELL STRUCTURE; CONTROLLED STUDY; DNA DAMAGE; DRUG MECHANISM; ENZYME ACTIVITY; HEPATOMA CELL; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION;

ANTINEOPLASTIC AGENTS, PHYTOGENIC; BREAST NEOPLASMS; CARCINOMA, HEPATOCELLULAR; CELL AGING; CELL LINE, TUMOR; CYCLIN-DEPENDENT KINASE INHIBITOR P21; DOWN-REGULATION; FEMALE; HUMANS; HYDROLYZABLE TANNINS; LIVER NEOPLASMS; REACTIVE OXYGEN SPECIES; S PHASE; TUMOR SUPPRESSOR PROTEIN P53;

EID: 79959932848     PISSN: 08991987     EISSN: 10982744     Source Type: Journal    
DOI: 10.1002/mc.20743     Document Type: Article

References (31)

1. Sporn MB, Suh N. Chemoprevention: An essential approach to controlling cancer. Nat Rev Cancer 2002; 2: 537-543.
2. Surh YJ. Cancer chemoprevention with dietary phytochemicals. Nat Rev Cancer 2003; 3: 768-780. Review.
3. Lambert JD, Yang CS. Cancer chemopreventive activity and bioavailability of tea and tea polyphenols. Mutat Res 2003; 523-524: 201-208. Review.
4. Khan N, Adhami VM, Mukhtar H. Green tea polyphenols in chemoprevention of prostate cancer: Preclinical and clinical studies. Nutr Cancer 2009; 61: 836-841. Review.
5. Thomasset SC, Berry DP, Garcea G, Marczylo T, Steward WP, Gescher AJ. Dietary polyphenolic phytochemicals-Promising cancer chemopreventive agents in humans? A review of their clinical properties. Int J Cancer 2007; 120: 451-458. Review.
6. Oh GS, Pae HO, Oh H, et al. In vitro anti-proliferative effect of 1, 2, 3, 4, 6-penta-O-galloyl-beta-D-glucose on human hepatocellular carcinoma cell line, SK-HEP-1 cells. Cancer Lett 2001; 174: 17-24.
7. Huh JE, Lee EO, Kim MS, et al. Penta-O-galloyl-β-d-glucose suppresses tumor growth via inhibition of angiogenesis and stimulation of apoptosis: Roles of cyclooxygenase-2 and mitogen-activated protein kinase pathways. Carcinogenesis 2005; 26: 1436-1445.
8. Lee HH, Ho CT, Lin JK. Theaflavin-3, 3'-digallate and penta-O-galloyl-β-d-glucose inhibit rat liver microsomal 5α-reductase activity and the expression of androgen receptor in LNCaP prostate cancer cells. Carcinogenesis 2004; 25: 1109-1118.
9. 1 phase arrest in MCF human breast cancer cells by pentagalloylglucose through the down-regulation of CDK4 and CDK2 activities and up-regulation of the CDK inhibitors p27(Kip) and p21(Cip). Biochem Pharmacol 2003; 65: 1777-1785.
10. Hua KT, Way TD, Lin JK. Pentagalloylglucose inhibits estrogen receptor α by lysosome-dependent depletion and modulates ErbB/PI3K/Akt pathway in human breast cancer MCF-7 cells. Mol Carcinog 2006; 45: 551-560.
11. Hu H, Chai Y, Wang L, et al. Pentagalloylglucose induces autophagy and caspase-independent programmed deaths in human PC-3 and mouse TRAMP-C2 prostate cancer cells. Mol Cancer Ther 2009; 8: 2833-2843.
12. 1-cell cycle arrests in prostate cancer cells targeting DNA replication and cyclin D1. Carcinogenesis 2009; 30: 818-823.
13. Hu H, Lee HJ, Jiang C, et al. Penta-1, 2, 3, 4, 6-O-galloyl-beta-D-glucose induces p53 and inhibits STAT3 in prostate cancer cells in vitro and suppresses prostate xenograft tumor growth in vivo. Mol Cancer Ther 2008; 7: 2681-2691.
14. Kuo PT, Lin TP, Liu LC, et al. Penta-O-galloyl-beta-D-glucose suppresses prostate cancer bone metastasis by transcriptionally repressing EGF-induced MMP-9 expression. J Agric Food Chem 2009; 57: 3331-3339.
15. Hayflick L, Moorhead PS. The serial cultivation of human diploid cell strains. Exp Cell Res 1961; 25: 585-621.
16. Gewirtz DA, Holt SE, Elmore LW. Accelerated senescence: An emerging role in tumor cell response to chemotherapy and radiation. Biochem pharmacol 2008; 76: 947-957.
17. Christov KT, Shilkaitis AL, Kim ES, Steele VE, Lubet RA. Chemopreventive agents induce a senescence-like phenotype in rat mammary tumours. Eur J Cancer 2003; 39: 230-239.
18. Heiss EH, Schilder YD, Dirsch VM. Chronic treatment with resveratrol induces redox stress- and ataxia telangiectasia-mutated (ATM)-dependent senescence in p53-positive cancer cells. J Biol Chem 2007; 282: 26759-26766.
19. Campisi J. Senescent cells, tumor suppression, and organismal aging: Good citizens, bad neighbors. Cell 2005; 120: 513-522.
20. Hornsby PJ. Senescence as an anticancer mechanism. J Clin Oncol 2007; 25: 1852-1857.
21. Li L, Shaik AA, Zhang J, et al. Preparation of penta-O-galloyl-β-d-glucose from tannic acid and plasma pharmacokinetic analyses by liquid-liquid extraction and reverse-phase HPLC. J Pharm Biomed Anal 2011; 54: 545-550.
22. Rothe G, Valet G. Flow cytometric analysis of respiratory burst activity in phagocytes with hydroethidine and 2', 7'-dichlorofluorescin. J Leukoc Biol 1990; 47: 440-448.
23. Jiang C, Wang Z, Ganther H, Lu J. Caspases as key executors of methyl selenium-induced apoptosis (anoikis) of DU-145 prostate cancer cells. Cancer Res 2001; 61: 3062-3070.
24. Alimonti A, Nardella C, Chen Z, et al. A novel type of cellular senescence that can be enhanced in mouse models and human tumor xenografts to suppress prostate tumorigenesis. J Clin Invest 2010; 120: 681-693.
25. Sharpless NE, DePinho RA. Cancer: Crime and punishment. Nature 2005; 436: 636-637.
26. Chen Q, Ames BN. Senescence-like growth arrest induced by hydrogen peroxide in human diploid fibroblast F65 cells. Proc Natl Acad Sci USA 1994; 91: 4130-4134.
27. Catalano A, Rodilossi S, Caprari P, Coppola V, Procopio A. 5-Lipoxygenase regulates senescence-like growth arrest by promoting ROS-dependent p53 activation. EMBO J 2005; 24: 170-179.
28. Goldstein S. Replicative senescence: The human fibroblast comes of age. Science 1990; 249: 1129-1133. Review.
29. Yaswen P, Campisi J. Oncogene-induced senescence pathways weave an intricate tapestry. Cell 2007; 128: 233-234. Review.
30. Chai Y, Lee HJ, Shaik AA, et al. Penta-O-galloyl-β-D-glucose induces G1 arrest and DNA replicative S-phase arrest independently of P21 cyclin-dependent kinase inhibitor 1A, P27 cyclin-dependent kinase inhibitor 1B and P53 in human breast cancer cells and is orally active against triple-negative xenograft growth. Breast Cancer Res 2010; 12: R67.
31. Mizushina Y, Zhang J, Pugliese A, Kim SH, Lü J. Anti-cancer gallotannin penta-O-galloyl-beta-D-glucose is a nanomolar inhibitor of select mammalian DNA polymerases. Biochem Pharmacol 2010; 80: 1125-1132.